ORY-1001, a potent and selective covalent KDM1A inhibitor, for the treatment of Acute Leukemia (Sample2)
收藏官方服务:
资源简介:
Sample2 THP-1 H3K4me2 ChIPSeq Data after ORY-1001 treatment
样本2:经ORY-1001处理后的THP-1细胞组蛋白H3赖氨酸4二甲基化(H3K4me2)染色质免疫共沉淀测序(ChIPSeq)数据
创建时间:
2018-03-05




